-
41
Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group
Published 2020-04-01Subjects: “…multiple myeloma…”
Get full text
Article -
42
Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
Published 2024-04-01Subjects: Get full text
Article -
43
Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram
Published 2025-01-01Subjects: “…multiple myeloma…”
Get full text
Article -
44
-
45
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia
Published 2024-09-01Subjects: Get full text
Article -
46
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
Published 2021-07-01Subjects: “…multiple myeloma…”
Get full text
Article -
47
Long-term trends in the burden of multiple myeloma in China: a Joinpoint regression and age-period-cohort analysis based on GBD 2021
Published 2025-02-01Subjects: “…multiple myeloma…”
Get full text
Article -
48
5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
Published 2024-12-01Subjects: Get full text
Article -
49
Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
50
The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen
Published 2025-01-01Subjects: Get full text
Article -
51
Elevated LIF and JAK-STAT activation drive severe COVID-19 in myeloma patients receiving the BCMA-CD3 bispecific antibody Elranatamab
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
52
Unveiling causal immune cell–gene associations in multiple myeloma: insights from systematic reviews and Mendelian randomization analyses
Published 2025-01-01Subjects: Get full text
Article -
53
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
Published 2025-01-01Subjects: Get full text
Article -
54
PNPO‐Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β‐Catenin Pathway
Published 2025-02-01Subjects: Get full text
Article -
55
Detection of early relapse in multiple myeloma patients
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
56
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
Published 2024-12-01Subjects: Get full text
Article -
57
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
Published 2025-02-01Subjects: Get full text
Article -
58
Anti-GluK2 antibody-positive autoimmune encephalitis concurrent with multiple myeloma: a case report
Published 2025-01-01Subjects: Get full text
Article -
59
A Nomogram Based on Circulating Inflammatory Factors for Predicting Prognosis of Newly Diagnosed Multiple Myeloma Patients
Published 2025-02-01Subjects: “…multiple myeloma…”
Get full text
Article -
60
Unmasking Multiple Myeloma: The Importance of Suspecting Malignancy in Atypical Chronic Pain Mimicking Degenerative Conditions—A Case Report
Published 2025-01-01Subjects: Get full text
Article